KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Total Non-Current Liabilities (2016 - 2021)

Abbott Laboratories (ABT) has disclosed Total Non-Current Liabilities for 13 consecutive years, with $15.8 billion as the latest value for Q4 2021.

  • Quarterly Total Non-Current Liabilities rose 94.31% to $15.8 billion in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $15.8 billion through Dec 2021, up 94.31% year-over-year, with the annual reading at $15.8 billion for FY2021, 94.31% up from the prior year.
  • Total Non-Current Liabilities hit $15.8 billion in Q4 2021 for Abbott Laboratories, up from $8.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $48.2 billion in Q4 2017 to a low of -$26.9 billion in Q4 2019.
  • Historically, Total Non-Current Liabilities has averaged $16.8 billion across 5 years, with a median of $15.8 billion in 2021.
  • Biggest five-year swings in Total Non-Current Liabilities: plummeted 169.72% in 2019 and later skyrocketed 130.26% in 2020.
  • Year by year, Total Non-Current Liabilities stood at $48.2 billion in 2017, then fell by 19.84% to $38.6 billion in 2018, then tumbled by 169.72% to -$26.9 billion in 2019, then skyrocketed by 130.26% to $8.2 billion in 2020, then surged by 94.31% to $15.8 billion in 2021.
  • Business Quant data shows Total Non-Current Liabilities for ABT at $15.8 billion in Q4 2021, $8.2 billion in Q4 2020, and -$26.9 billion in Q4 2019.